Circle Pharma
Roberta Sala, PhD, obtained her B.S. and M.S. in Molecular Biology from the University of Padua, Italy. She moved to Imperial College London, U.K. for her PhD in Clinical Oncology in Prof. Eric Aboagye group where she was studying the detection of cancer proliferation with PET imaging. Before joining Circle Pharma, she was first a postdoctoral scholar working on centrosome biology in Prof. Tim Stearns’ lab in the Biology Department and then an Instructor in Prof. Vittorio Sebastiano’s lab in the OB/GYN Department at Stanford University where she was working on the differentiation of stem cells into germ cells.
This person is not in any offices
Circle Pharma
2 followers
Circle Pharma, Inc. initiated operations in June 2014 with seed funding from Pfizer, Inc. and Mission Bay Capital, LLP; we received additional seed funding from ShangPharma Investment Group Limited in November 2015. We recently raised Series B and Series C financing from The Column Group and NextTech Invest.